PopSole2: Validation of a Novel Foot Offloading Device

Sponsor
Jeffrey A. Gusenoff, MD (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04378270
Collaborator
(none)
20
2
1
27.2
10
0.4

Study Details

Study Description

Brief Summary

Pressure offloading is often considered the most crucial aspect in healing after a foot injury. The investigators have devised a novel foot offloading device (PopSole™) which will allow for customization of the area where there is foot pain, as well as allow for customizable arch support and elevation of the metatarsals. This validation study is aimed to assess improvement of pain with use, ease of use, fit and feel, compliance, and durability over a 4 week period. Validated patient reported outcome measures will be used at baseline, 2 weeks and 4 weeks.

Condition or Disease Intervention/Treatment Phase
  • Device: PopSole™ Offloading Device
N/A

Detailed Description

All subjects will receive the PopSole™ offloading device at the screening/baseline visit, be asked to wear it for 4 weeks, and will be asked to return for an in-person evaluation at week 2 and a completion study visit at week 4.

Screening includes the following procedures:
  1. Performance of a limited physical exam, inclusive of participant's foot exam with a gait and shoe gear evaluation.

  2. Medical and surgical history collection

  3. Vital signs, medication profile, allergies, height, weight, and BMI calculation.

  4. Collection of demographic information

  5. 2D Photographs of both feet will be performed

Subjects will be asked to complete:
  1. Questionnaires
  • Foot and Ankle Ability Measure questionnaire

  • Mayo Clinical Scoring System questionnaire

  • American Orthopaedic Foot and Ankle Society questionnaire

  • Manchester Foot and Ankle Disability Index

  • Pittsburgh Foot Survey

  1. Diary cards to document for the feet: pain, bruising, redness of the skin, itching, swelling, bleeding, and any concerns/issues not listed, as well as the location, date and day for each noted symptom.

  2. Offload Device Distribution. Devices will be provided for both feet to maintain symmetry and gait stability between the two feet. One pair of devices will be given for use in shoe gear, and one pair will be given for use in a slide in the shower.

Follow up visit procedures:

Week 2

  1. Collection of vital signs, medication profile, weight, and BMI calculation

  2. Limited physical exam with a foot exam

  3. Adverse Event Reporting

  4. Collection and distribution of feet diary cards

  5. 2D Photographs of both feet

  6. Foot Assessment Questionnaires

  7. Device survey - questions about the fit and feel of the device

Week 4

The same procedures listed for week 2, with the addition of PopSole™ Device removal and final foot diary card collection.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Validation of a Novel Foot Offloading Device
Actual Study Start Date :
Aug 26, 2020
Actual Primary Completion Date :
Oct 20, 2021
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: PopSole™ offloading device

This is an external insole device that fits into a shoe and is reusable for a given subject, not for one-time use. It is comparable to other off-the-shelf insoles readily available and presents minimal risk to the participant during the four weeks of study participation.

Device: PopSole™ Offloading Device
Specifically, the PopSole™ Offloading Device allows the provider to pop bubbles in the device (like popping paper or plastic bubble sheeting), thereby offloading the surgical area or area of pain. This customizable approach to offloading may increase compliance as it can easily fit in a normal walking shoe and is personalized for each patient. It can also be attached to a slide for use in the shower. Currently no post-operative devices for offloading the foot can be used in the shower.

Outcome Measures

Primary Outcome Measures

  1. Change in foot pain from screening visit to week 4 visit as reported on the Pittsburgh Foot Survey. [Four Weeks]

    Pain and function questionnaire measure. Scale for pain ranges from "Very severe" to "Had no pain". Scale for pain interference ranges from " Very much" to "not at all". Scale of functionality ranges from "unable to do" to "without any difficulty" in regards to a range of specified activities. There is no overall summation of results.

  2. Change in foot pain from screening visit to week 4 visit as reported on the Manchester Foot and Ankle Index. [Four Weeks]

    Pain and function questionnaire assessment. Three responses to a variety of pain and specified activities raging from "On most/every day(s)" which is scored as 2 to "none of the time" which is scored as 0. Summation is made on Functional (0-20 with 20 being the lowest functioning), Personal appearance (0-4 with 4 being the worst), pain (0-10 with 10 being the worst), work/leisure (0-100 with 100 being the worst impact on work/leisure).

  3. Change in foot pain from screening visit to week 4 visit as reported on the Mayo Clinical Scoring System Questionnaire. [Four Weeks]

    Pain and function questionnaire. Pain scale from 0 (worst) to 50 (no pain). Activity limitations, orthotic requirements, antalgic gait, neuropathy and plantar heel tenderness are all graded 10 (best) to 10 (worst). Overall summation is excellent (90-100), good (80-89), fair (70-79), poor (<70)

  4. Change in foot pain from screening visit to week 4 visit as reported on the American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Scale. [Four Weeks]

    This survey assesses pain (40 points possible, comprises pain subtotal), function (50 points possible, comprises function subtotal; which includes activity limitations, maximum walking distance, difficulty with walking surfaces, gait abnormality, sagittal motion, hindfoot motion and ankle/hindfoot stability, and alignment (10 possible points, comprises alignment subtotal). A total score is calculated out of 100, with higher scores indicating greater impairment. There are also calculated subtotals specific to pain, function and alignment.

  5. Device durability [Four weeks.]

    Documentation of the number of participants who wore a single device for the full 4 weeks of the participant's study participation.

  6. Participant compliance with device [Four Weeks]

    Documentation of the number of participants who did not wear a single device for the full 4 weeks of the participant's study participation, and the duration of time for each participant that the device was worn before it was replaced.

Secondary Outcome Measures

  1. Participants' reported satisfaction and/or difficulties with the device. [Four Weeks]

    As measured by subject self report, using a device satisfaction measure questionnaire. Questions are answered yes/no in all cases except comfort (1-10 with 10 being the most comfortable), and ease of use (1-10 with 10 being most easy to use).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Aged 18 years or older and able to provide informed consent

  2. Subjects with foot pain due to forefoot or heel fat pad atrophy or chronic plantar fasciitis as defined by heel pain for greater than 6 months and failed non-surgical therapy

  3. Willing and able to comply with follow up examinations

Exclusion Criteria:
  1. Concurrent injury to the lower extremity that would effect gait

  2. Open foot ulcerations, fractures, or diagnosis of osteomyelitis of the feet

  3. Surgical foot intervention in the last 6 months

  4. Diagnosis of pregnancy or the intent of the participant to become pregnant during participation in this study

  5. Neuropathy

  6. Any issue that per the physician's determination would render the patient not appropriate to continue participation in the study (compliance, change in physical status, etc.)

Contacts and Locations

Locations

Site City State Country Postal Code
1 UPMC Lemieux Sports Medicine Complex Cranberry Township Pennsylvania United States 16066
2 UPMC Aesthetic Plastic Surgery Center Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • Jeffrey A. Gusenoff, MD

Investigators

  • Principal Investigator: Jeffrey Gusenoff, MD, Professor of Plastic Surgery, Director of the Foot Fat Grafting Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jeffrey A. Gusenoff, MD, Professor of Plastic Surgery, & Director, Foot Fat Grafting Institute, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04378270
Other Study ID Numbers:
  • STUDY20010059
First Posted:
May 7, 2020
Last Update Posted:
Jan 11, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2022